Sat, Sep 20, 2014, 6:58 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Curis, Inc. Message Board

  • jan31 jan31 Dec 20, 2012 9:08 AM Flag

    vismodegib named Drug Discovery of the Year by the British Pharmacological Society

    http://www.roche.com/investors/ir_update/inv-update-2012-12-20.htm

    Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the first in class Hedgehog pathway inhibitor vismodegib, was named Drug Discovery of the Year by the British Pharmacological Society. The award, which celebrates the importance of pharmacology in the development of new medicines, was presented to the vismodegib team because of the detailed pharmacokinetic/pharmacodynamic analysis that was completed during the drug development process. Vismodegib is currently approved in the US and Mexico for the treatment of adults with an advanced form of the common skin cancer basal cell carcinoma.

 
CRIS
1.52-0.04(-2.56%)Sep 19 4:15 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.